There’s still time to register for our August 21 webinar on measuring and conveying the impact of Medical Affairs. Join IQVIA’s Diana Morgenstern and Javier Lopez-Molina to learn how to identify potential means of measuring impact, understand the metrics that contribute to it, and develop a data-driven approach to conveying its value to internal and external stakeholders. https://bit.ly/46MX9BI #medaffairs
IQVIA
Hospitals and Health Care
Durham, North Carolina 2,078,108 followers
Accelerate innovation for a healthier world.
About us
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
- Website
-
https://www.iqvia.com/
External link for IQVIA
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Durham, North Carolina
- Type
- Public Company
- Specialties
- Technology, Consulting, and Clinical Development
Locations
-
Primary
2400 Ellis Rd
Durham, North Carolina 27703, US
Employees at IQVIA
Updates
-
IQVIA Healthcare-grade AI™ worked with the UK National Health Service to improve the prediction of strokes in high-risk patients, enabling them to take preventative steps and reduce strokes in the initial testing phase by 22%. Learn more at https://lnkd.in/gicm82gm
-
IQVIA's Health Research Space platform is designed to meet the needs of real world direct-to-patient decentralized studies. It offers a seamless experience for participants in real world research, improving participation, reducing start-up times, and enabling study progress monitoring. Learn more. https://bit.ly/3YzOIrj #RWE
-
-
Picture this: you have 12 weeks to get a recall done...
Picture this: you have 12 weeks to get a recall done – with multiple countries, numerous languages, and hundreds of consignees to contact. Oh, and you don’t have the internal resource or expertise to help. You’re not recall ready, but you should be. Talk to IQVIA MedTech about how we can bring you up to speed. https://lnkd.in/e3QhYqKn #Recall #MedicalDevices #MedTech
-
Learn about clinical trial global diversification trends in this new report from the IQVIA Institute.
🔍 New report out now: Rethinking Clinical Trial Country Prioritization The biopharma clinical research ecosystem has undergone significant evolution over the past five years due to technological, environmental, societal, regulatory, and geopolitical shifts. These changes have reshaped clinical trial activities and operations, bringing both opportunities and challenges. 📊 Our latest report explores: ✅ The emergence of new global players in clinical trials. ✅ Execution challenges, delays, capacity concerns, and uncertainties impacting clinical development timelines and patient outcomes. ✅ The critical focus on global diversification of clinical trials. ✅ Trends in enrollment timelines, trial characteristics, and country utilization. ✅ Exploration of countries with high patient recruitment potential. Get your copy of the report: https://lnkd.in/erWtB-qG #ClinicalTrials #GlobalHealth #HealthEquity
-
-
The role of Medical Affairs continues to evolve as a strategic partner within an organization. Join IQVIA’s Diana Morgenstern and Javier Lopez-Molina August 21 for a webinar to explore the growing impact of Medical Affairs and discuss a framework for measuring and demonstrating value to internal and external stakeholders. https://bit.ly/3SEksHW #medaffairs
-
-
Looking for a career that energizes and excites you? IQVIA is committed to enabling healthcare transformation to improve people's lives around the world. Find out where your skills fit in: https://bit.ly/3ykCeZZ #WeAreIQVIA
-
-
Are you passionate about advancing technology? Are you fascinated by data and using it to make a real impact? Help IQVIA transform the future of healthcare in a career in technology and analytics: https://bit.ly/3yhKWIq #WeAreIQVIA #NowHiring
-
-
Looking for industry-leading #RealWorldEvidence perspectives? Access #IQVIA's Real World Evidence Library for expert content to help you meet stakeholder needs with confidence and get real results. https://bit.ly/46w8MN0
-
If you haven't already, make sure to subscribe to IQVIA #GlobalMarketInsights newsletter to receive GMI's latest #pharmaceuticalmarket insights directly in your mailbox. The team provides monthly updates on the patent protection, pipeline watch, new product development, pharma deals, market forecasts and more. Don't miss out on these key insights and stay ahead of innovation!
Explore the latest #pharmaceuticalmarket insights in this month’s INNsight Newsletter. Discover the latest novel treatments for #myastheniagravis (MG) and ongoing clinical trials. The white paper on advanced #omnichannel capabilities and infrastructure provides valuable insights for enhancing #HCP engagement. Plus, delve into the #Hematologic Cancer Opportunities for Patient Equality (HOPE) report, which quantifies trends related to therapies for hematological malignancies across selected countries. Click through to read the articles. Subscribe to IQVIA #GlobalMarketInsights monthly newsletter to receive future insights directly in your mailbox. #INNsightNewsletter #PipelineLink #IQVIAInstitute
Affiliated pages
Similar pages
Browse jobs
Stock
IQV
NYSE
20 minutes delay
$231.46
-6.01 (-2.531%)
- Open
- 235.82
- Low
- 230.81
- High
- 236.79
Data from Refinitiv
See more info on